NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against Indivior PLC (“Indivior” or the “Company”) (OTCMKTS: INVVY), and certain other defendants, related to alleged violations of federal securities laws. If you purchased Indivior American Depository Receipts (“ADRs”) between March 10, 2015 and April 9, 2019, you are encouraged to contact a Scott+Scott attorney at (888) 398-9312 for more information.
Indivior develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence.
The complaint alleges that defendants made false and/or misleading statements and/or failed to disclose that: (1) Indivior and its executives engaged in an illicit nationwide scheme to increase prescriptions of Suboxone Film; (2) Indivior illegally obtained billions of dollars in revenue from Suboxone Film prescriptions by deceiving health care providers and health care benefit programs; (3) as a result, Indivior would face felony charges; and (4) due to the foregoing, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
On April 9, 2019, the U.S. Department of Justice filed an indictment asserting criminal charges against Indivior in connection with the Company’s conduct in marketing Suboxone Film. The charges included one count of conspiracy to commit mail, wire, and health care fraud, one count of health care fraud, four counts of mail fraud, and twenty-two counts of wire fraud. The indictment described the fraudulent marketing scheme in extensive detail.
On this news, the price of Indivior ADRs fell $4.48 – over 66% – to close at $2.30 per ADR on April 10, 2019.
What You Can Do
If you purchased Indivior ADRs between March 10, 2015 and April 9, 2019, inclusive, or if you have questions about this notice or your legal rights, please contact attorney Jonathan Zimmerman at (888) 398-9312 or jzimmerman@scott-scott.com. The lead plaintiff deadline is June 24, 2019.
About Scott+Scott Attorneys at Law LLP
Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.
Attorney Advertising
